132765-Thumbnail Image.png
Description

Recently, we have demonstrated that a novel RNA origami (RNA-OG) nanostructure functions as a TLR3 agonist both in vitro and in vivo. This RNA nanostructure could induce effective antitumor immunity in a CT26-OVA-iRFP tumor model that expresses both ovalbumin (OVA)

Recently, we have demonstrated that a novel RNA origami (RNA-OG) nanostructure functions as a TLR3 agonist both in vitro and in vivo. This RNA nanostructure could induce effective antitumor immunity in a CT26-OVA-iRFP tumor model that expresses both ovalbumin (OVA) and near infrared protein (iRFP), rendering a significant delay in tumor growth or complete tumor-regression.

2.05 MB application/pdf

Download restricted. Please sign in.

Download count: 0

Details

Contributors
Date Created
2019-05
Resource Type
  • Text
  • Machine-readable links